Acute Porphyria Drugs

C07AA03 - Pindolol

Propably not porphyrinogenic
PNP

Rationale
Beta-blocker. Clinical experience and wo references point to non-porphyrinogenicity.
Chemical description
Beta-receptor blocking agent used in hypertonia, angina pectoris, tachyarrythmia. Eliminated unchanged (30 -40%) and as metabolites. Thunell, patient reports (n=3): tolerated. Andersson, patient report (n=3): tolerated. South African list: use. EPI: safe (betablockers)
IPNet drug reports
Uneventful use reported in 5 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes C07A / C07AA or go back.
References
Tradenames

Visken Pindolol · Visken Visken Pindolol · Visken Visken Betadren · Pindolol · Visken Pindolol
In cooperation with Ipnet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙